Slingshot members are tracking this event:
DBV Tech (DBVT) Completes Enrollment for Phase 2b MILES Study Evaluating Viaskin Milk for Patients Ages 2-17 with IgE-mediated Cow's Milk Protein Allergy (CMPA)
Slingshot Insights Explained
Nov 08, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Enrollment, Phase 2b, Miles, Viaskin Milk, Ige-mediated, Cow's Milk Protein Allergy, Cmpa